HCA Healthcare Inc (HCA)

NYSE · Healthcare · Medical Care Facilities · USA

HCA Healthcare Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Care Facilities industry.

HCA Healthcare operates a network of hospitals and outpatient facilities across the United States and England. The company owns and operates general acute care hospitals, behavioral hospitals, rehabilitation hospitals, ambulatory surgery centers, and freestanding endoscopy centers. Its facilities provide comprehensive health care services including inpatient care, emergency services, surgical procedures, diagnostic services, and various outpatient offerings.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the HCA Healthcare Inc stock.

Our verdict on HCA

Undervalued: intrinsic value $664.43 per share, market price $454.88, margin of safety 31.5% (as of 2026-10-19).

Discounting its cash flows at 8.8% (average of 3 methods) values the shares at $664.43; the price of $454.88 is 32% below that value, and 77% of that value comes from beyond year five.

Leak Score: 90/100 on 9 of 12 signals (Major Leak).

ETFs with the most weight in HCA

17 more funds hold it; the full list is part of the paid plan.

More on HCA

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Compare side by side

Cheaper than HCA in Medical Care Facilities

3 more in this industry show a wider margin of safety.

Is HCA undervalued or overvalued?

HCA is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 8.8% (average of 3 methods) values the shares at $664.43; the price of $454.88 is 32% below that value, and 77% of that value comes from beyond year five.

What is the intrinsic value of HCA?

$664.43 per share (as of the 2026-10-19 close), against a market price of $454.88. That is a margin of safety of 31.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What growth is priced into HCA stock?

The price asks for less growth than the company has already delivered. Repeating its past would be enough. Yearly sales decline the price allows: 1.6%. Yearly sales growth it has sustained: 7.9%.

What is HCA Healthcare Inc's Leak Score?

90 out of 100, which we rate "Major Leak", on 9 of 12 value investing signals.